GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 14 filers reported holding GENETIC TECHNOLOGIES LTD in Q4 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $69,962 | +89.1% | 76,881 | +148.2% | 0.00% | – |
Q3 2022 | $37,000 | -37.3% | 30,980 | -40.1% | 0.00% | – |
Q2 2022 | $59,000 | -57.9% | 51,703 | -27.2% | 0.00% | – |
Q1 2022 | $140,000 | -55.1% | 70,993 | -57.2% | 0.00% | – |
Q4 2021 | $312,000 | +40.5% | 165,920 | +130.2% | 0.00% | – |
Q3 2021 | $222,000 | -63.1% | 72,072 | -49.1% | 0.00% | – |
Q2 2021 | $602,000 | +20.2% | 141,626 | +18.1% | 0.00% | – |
Q1 2021 | $501,000 | -51.9% | 119,927 | -58.6% | 0.00% | – |
Q4 2020 | $1,042,000 | +151.1% | 289,424 | +141.4% | 0.00% | – |
Q3 2020 | $415,000 | – | 119,916 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 13,357 | $41,000 | 0.00% |
BREWIN DOLPHIN LTD | 20 | $62 | 0.00% |
ROYAL BANK OF CANADA | 3,000 | $9,000 | 0.00% |
UBS Group AG | 75 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 62,408 | $193,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 17,199 | $53,000 | 0.00% |
MORGAN STANLEY | 30,113 | $93,000 | 0.00% |
Citadel Advisors | 28,500 | $88,000 | 0.00% |
Citadel Advisors | 21,500 | $66,000 | 0.00% |